← back to search

Bin Cao

Xi'an University of Science and Technology · CN
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Respiratory viral infections research, Pneumonia and Respiratory Infections, Influenza Virus Research Studies, and COVID-19 Clinical Research Studies.
h-index
80
citations
127,036
works
582
NIH funding
primary concept
Medicine
email

Recent publications

Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine 2025cited by 52position: middledoi
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Nature Medicine 2025cited by 16position: lastdoi
Influenza A virus dissemination and infection leads to tissue resident cell injury and dysfunction in viral sepsis
EBioMedicine 2025cited by 15position: lastdoi
High-level ceftazidime-avibactam resistance by in-host evolution of blaKPC genes: Emergence of a novel blaKPC-102 variant and increase of blaKPC-33 copy number in Klebsiella pneumoniae strains from a lung transplantation recipient
International Journal of Antimicrobial Agents 2025cited by 4position: lastdoi
Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
The Journal of Infectious Diseases 2025cited by 2position: lastdoi
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial
Nature Communications 2025cited by 1position: lastdoi
Author Correction: Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Nature Medicine 2025cited by 1position: lastdoi
Immune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms
Open Forum Infectious Diseases 2024cited by 4position: lastdoi
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID‐19 Survivors: A 2‐Year Cohort Study
Influenza and Other Respiratory Viruses 2024cited by 1position: lastdoi
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
The Lancet 2023cited by 889position: lastdoi
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
The Lancet Digital Health 2023cited by 154position: middledoi
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
The Lancet Respiratory Medicine 2023cited by 123position: middledoi
Long COVID in low-income and middle-income countries: the hidden public health crisis
The Lancet 2023cited by 50position: lastdoi
The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza
Antiviral Research 2023cited by 11position: lastdoi
Comprehensive immune landscape of lung-resident memory CD8+ T cells after influenza infection and reinfection in a mouse model
Frontiers in Microbiology 2023cited by 9position: lastdoi
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
The Lancet Respiratory Medicine 2022cited by 602position: lastdoi
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
The Lancet Respiratory Medicine 2022cited by 229position: middledoi
Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study
EBioMedicine 2022cited by 56position: lastdoi
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
European Respiratory Journal 2022cited by 45position: middledoi
Risk factors for polymyxin B-associated acute kidney injury
International Journal of Infectious Diseases 2022cited by 31position: lastdoi
Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
Frontiers in Medicine 2022cited by 29position: lastdoi
Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells
Emerging Microbes & Infections 2022cited by 28position: lastdoi
Titanium-coated PEEK Versus Uncoated PEEK Cages in Lumbar Interbody Fusion
Clinical Spine Surgery A Spine Publication 2022cited by 17position: middledoi
Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19): A Chronic Post–COVID-19 Condition
Open Forum Infectious Diseases 2022cited by 9position: lastdoi
Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic
National Science Review 2022cited by 6position: middledoi
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
The Lancet 2021cited by 4,274position: lastdoi
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
The Lancet Digital Health 2021cited by 526position: middledoi
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
European Respiratory Journal 2021cited by 229position: middledoi
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Emerging Microbes & Infections 2021cited by 104position: middledoi
Association of fine particulate matter air pollution and its constituents with lung function: The China Pulmonary Health study
Environment International 2021cited by 94position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yeming Wang · Academy of Medical Sciences17 papers (2020–2025)Xiaoying Gu · Chinese Academy of Medical Sciences & Peking Union Medical College8 papers (2020–2022)Yunsong Yu · Hangzhou Normal University8 papers (2012–2017)Bijie Hu · Sun Yat-sen University8 papers (2012–2017)Chen Wang · Stanford University8 papers (2012–2025)Yingchun Xu · Harbin Medical University7 papers (2012–2017)Kang Liao · Sun Yat-sen University7 papers (2012–2017) · 7 papers (2012–2017)Hui Wang · Peking University7 papers (2012–2019)Zhidong Hu · Fudan University7 papers (2012–2017)Ziyong Sun · Tongji Hospital7 papers (2012–2017)Jianwei Wang · Chengdu University of Traditional Chinese Medicine7 papers (2020–2024)Lixue Huang · Chinese Academy of Medical Sciences & Peking Union Medical College6 papers (2022–2024)Dan Cui · Shanghai East Hospital6 papers (2022–2024) · 5 papers (2013–2017) · 5 papers (2015–2017)Xiaohui Zou · Tsinghua University5 papers (2020–2023)Jiuyang Xu · Laboratoire de Synthèse Organique5 papers (2020–2022)Li Guo · Intelligent Health (United Kingdom)5 papers (2020–2024)Shufang Zhang · Chongqing University4 papers (2015–2017)